Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quebec Precious Metals Corporation V.QPM

Alternate Symbol(s):  CJCFF

Quebec Precious Metals Corporation is a Canada-based gold explorer with a land position in the prospective Eeyou Istchee James Bay territory, Quebec, near Newmont Corporation’s Eleonore gold mine. The Company focuses on advancing its Sakami gold project and its newly discovered, drill-ready Ninaaskuwin lithium showing on the Elmer East project. In addition, the Company holds a 68% interest in the Kipawa rare earths project located near Temiscaming, Quebec. The Sakami project consists of one large contiguous block of 281 mineral claims and includes the contiguous claims, which are located 90 km northwest of the Eleonore mine, 570 km north of Val-d'Or and 900 km northwest of Montreal. The Cheechoo-Eleonore Trend project lies about 24 km northwest of the Eleonore mine. The Elmer East project consists of 929 claims, which is located along a trend from the recent Patwon Prospect gold discovery made by Azimut Exploration Inc. It also holds interest in the Matheson Joint Venture project.


TSXV:QPM - Post by User

Comment by cpacon Nov 28, 2004 9:33pm
230 Views
Post# 8239478

RE: technical analysis update

RE: technical analysis updatePlexor, Just wanted to start by saying... never invest more money in a stock than you can afford to lose. Having said that, if you are getting jittery, you could always sell 1/2 your shares before news comes out to protect yourself. However, and I don't mean to be harsh, but you really have to spend some time thinking about why you invested in Conjuchem in the first place. I did so because I believe they have the potential for a best in class diabetes treatment, the market for which, based on my research, UNFORTUNATELY!! will continue to grow at an alarming rate. The market is so robust that the valuation models that the analysts are using to come to their price targets suggest earnings of $2.XX in years ahead once the product goes to market. (To say nothing of the other products in their pipeline.) Now, I spoke with investor relations in order to raise my comfort level that the two trials currently underway (or finished for all I know) can reasonable be expected resolve the problem of nausea. If that proves out in the next couple weeks, I genuinely see no reason why the stock wouldn't return to it's previous double digit levels. Cheers, Cpac.
Bullboard Posts